CPA believes that foreign adversaries like China should not be able to exploit U.S. capital markets and tens of millions of unwitting American investors in order to fund activities that pose a threat to U.S economic and national security.
In order to protect retail investors and pensioners, CPA believes that companies should only be able to access U.S. capital markets if they are in compliance with all U.S. laws for transparency and accountability. Additionally, any company, including its subsidiaries, sanctioned by the U.S. government should be prohibited from accessing our markets, and no American investor — retail or institutional — should be able to invest in any financial product of a sanctioned company, including securities and other investment products like Exchange Traded Funds (ETFs).
U.S. investors are inadvertently funding Chinese companies involved in activities contrary to the national security, economic security, and human rights interests of the United States. For decades, Wall Street has profited by helping the Chinese Communist Party (CCP) fund its companies via U.S. capital markets, exploiting tens of millions of unwitting American investors in the process. Currently, there are Chinese companies integrated into U.S. capital markets that actively assist the CCP and its campaign of evil, including Beijing’s genocide and human rights abuses against the Uyghurs and companies helping to strengthen and modernize the People’s Liberation Army, Navy, and Air Force.
CPA advocates for the inclusion of more companies on existing sanctions lists, as well as creating new sanctions to protect American investors from these harmful companies that not only pose material risk to the return on investment, but also threats to American security. Via legislative, regulatory, and executive branch tools, CPA advocates for a U.S. government strategy that cuts off funding to the CCP and protects hard-earned investment capital.
House Speaker Mike Johnson (R-LA) and Senate Majority Leader Chuck Schumer (D-NY) each have expressed their desire to move forward this Congress with a bill to prohibit U.S. capital, economic incentives, and trade preferences from benefitting China and other adversarial nations. Importantly, this legislative package would also seek to build American productive capacity to eliminate dependence on those nations, especially in industries that are critical to U.S. economic and national security. The Coalition for a Prosperous America (CPA) endorses the following legislation for inclusion in any such package.
A smart policy like the ‘PILLS Act’ would prioritize domestic production of essential generics. It’s precisely the market signal needed to attract serious investment and rebuild the industry at home.
Under the so-called “Big Beautiful Bill” as passed by the House, Chinese solar companies will no longer qualify for renewable energy tax benefits under the Inflation Reduction Act (IRA) of 2022.
Some Chinese solar power inverters were allegedly found to have communication devices attached to them that were not supposed to be part of that equipment, suggesting that they can ping information back to the company’s headquarters and be used for nefarious ends, Reuters London reported on May 14.
The Trump Administration is leading a realignment on trade, moving away from a unipolar system that really had Asia as the Western world’s manufacturing hub. That is no longer feasible, or affordable.
CPA’s submission documents how the domestic trucking sector underpins U.S. commerce, and that ensuring a domestic industrial base for producing these trucks is vital to military readiness and civil emergency response.
As the leading organization advocating for reshoring the generic drug industry, CPA’s submission documents how extreme overreliance on foreign pharmaceutical supplies—especially active pharmaceutical ingredients (APIs) and critical injectable drugs from China and India—poses an urgent threat to U.S. national security and patient safety.
